Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment

Author： Perrin Christophe   Fabre Cédric   Raoul Jean-Luc   Boucher Eveline  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.8, 2006-12, pp. : 1135-1136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature

By                    

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3749-3755

Spandidos Publications

Access to resources Recommend Favorite

Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A metaanalysis

By          

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1915-1920

Spandidos Publications

Access to resources Recommend Favorite

Cetuximab in the treatment of colorectal cancer

By Ciardiello Fortunato   De Vita Ferdinando   Orditura Michele   Comunale Daniela   Galizia Gennaro  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 173-181

Future Medicine

Access to resources Recommend Favorite

Emerging Role of Cetuximab in the Treatment of Colorectal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 2, 2012-05 ,pp. : 233-247

Bentham Science Publishers

Access to resources Recommend Favorite

Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature

By Sonnenblick Amir   Meirovitz Amichay  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 420-422

Springer Publishing Company

Access to resources Recommend Favorite